webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Bocaminooxyacetamide-PEG2-Azido

  CAS No.:   Cat No.: BADC-01234   Purity: 98.0% 4.5  

Bocaminooxyacetamide-PEG2-Azido is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

Bocaminooxyacetamide-PEG2-Azido

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C13H25N5O6
Molecular Weight
347.37
Shipping
Room temperature
Shipping
Store at -5°C,keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Solubility
10 mm in DMSO
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
Room temperature
Storage
Store at -5°C,keep in dry and avoid sunlight.

Bocaminooxyacetamide-PEG2-Azido, a multifunctional chemical compound, finds its first key application in the field of bioconjugation. This compound is designed with reactive azide and oxyacetamide groups which facilitate the formation of stable conjugates with various biomolecules, such as proteins, peptides, and antibodies. The presence of polyethylene glycol (PEG) enhances the solubility and stability of the conjugates, making it ideal for developing bioconjugated molecules that can be used in a multitude of biological assays and therapeutic applications. The controlled and specific attachment of these biomolecules via Bocaminooxyacetamide-PEG2-Azido allows researchers to create more effective targeted drug delivery systems and diagnostic tools, leading to advancements in personalized medicine.

Another critical application of Bocaminooxyacetamide-PEG2-Azido is in click chemistry, a class of biocompatible small molecule reactions commonly used to quickly join substrates of interest. The azido group in Bocaminooxyacetamide-PEG2-Azido makes it an excellent candidate for copper-catalyzed azide-alkyne cycloaddition (CuAAC), one of the most popular click reactions. This reaction strategy is widely utilized in the synthesis of complex molecules, drug development, and the creation of functionalized polymers and materials. The high efficiency, specificity, and bio-orthogonality of the click reaction ensure that it can proceed without interfering with other bioactive molecules, underlining its importance in chemical biology and materials science.

In the realm of imaging and diagnostic techniques, Bocaminooxyacetamide-PEG2-Azido holds significant promise due to its modularity and versatility. The compound’s ability to covalently attach to various imaging agents, such as fluorescent dyes or radionuclides, enables the creation of highly specific imaging probes. These probes can be used for in vivo imaging to monitor biological processes, track disease progression, or evaluate the efficacy of therapeutic interventions. Furthermore, the PEGylation minimizes non-specific interactions and enhances the bioavailability and circulation time of the probes, thereby improving the sensitivity and specificity of the diagnostic assays. Such advancements in imaging techniques contribute to better disease diagnosis and monitoring.

Lastly, Bocaminooxyacetamide-PEG2-Azido is pivotal in the development of advanced biomaterials. The functionality provided by the azido and oxyacetamide groups allows for the straightforward modification of surfaces and the creation of multifunctional materials. For example, in tissue engineering and regenerative medicine, Bocaminooxyacetamide-PEG2-Azido can be utilized to functionalize scaffolds with bioactive molecules such as growth factors or cell adhesion peptides, promoting cell growth and differentiation. Similarly, it can be employed to coat medical devices and implants with antimicrobial peptides or other therapeutic agents, reducing the risk of infection and improving the integration of implants with the surrounding tissues. These applications are instrumental in the advancement of biomaterial science and the improvement of patient outcomes in various medical treatments.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Methyltetrazine-PEG5-nhs ester | Asn-Pro-Val-PABC-MMAE (TFA) | Methyltetrazine-PEG12-acid | MDTF (free acid) | MC-GGFG-NH-CH2-O-CH2-(s-cyclopropane)-COOH | Azide-PEG5-Tos | Fmoc-Asn-Pro-Val-PABC-PNP | NMS-P945 | Methyltetrazine-SS-PEG4-Biotin | Tetra-O-acetyl-β-D-galactopyranosyl-Ph-CH2-(4-nitrophenyl)carbonate-Fmoc | Bocaminooxyacetamide-PEG2-Azido
Send Inquiry
Verification code
Inquiry Basket